Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Comparative Evaluation of the Effectiveness of Nivolumab Versus Axitinib in the Second-Line Treatment of Patients with Metastatic Renal Cell Carcinoma: A Two-Center Experience

Objectives: This study aimed to compare the effectiveness of nivolumab and axitinib as second-line treatments in patients with metastatic renal cell carcinoma (mRCC) who had progressed after one prior tyrosine kinase inhibitor (TKI)-based therapy. Methods: We retrospectively evaluated 68 patients with mRCC who received...

Irfan Bugday, İ. D. Onur, M. Inanc et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.